GB1287839A - - Google Patents
Info
- Publication number
- GB1287839A GB1287839A GB5640770A GB5640770A GB1287839A GB 1287839 A GB1287839 A GB 1287839A GB 5640770 A GB5640770 A GB 5640770A GB 5640770 A GB5640770 A GB 5640770A GB 1287839 A GB1287839 A GB 1287839A
- Authority
- GB
- United Kingdom
- Prior art keywords
- formula
- salts
- cis
- antipode
- trione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1287839 (+) - Cis - 1,3 - dibenzyl - hexahydro - 1 H - furo[3,4 - d]imidazole - 2,4 - dione F. HOFFMAN-LA ROCHE & CO AG 27 Nov 1970 [29 Nov 1969] 56407/70 Headings C2C and C2U (+) - Cis - 1,3 - dibenzyl - hexahydro - 1H- furo[3,4-d]imidazole-2,4-dione of the formula wherein the rings A and B are cis-linked and R represents benzyl, may be obtained by converting the trione of formula by means of cholesterol or cyclohexanol into the corresponding half-esters of the formulµ wherein R 1 represents the cholesteryl or cyclohexyl residue, separating the cholesterol halfesters from each other by fractional crystallization of their triethylamine salts and the cyclohexyl half-esters from each other by fractional crystallization of their ephedrine salts, converting the salts of the desired antipode thus obtained into the compound of Formula I, and optionally hydrolysing the salts of the undesired antipode and recycling the racemate, after conversion into the trione of Formula (II), into the process. The salts of the desired antipode of Formula (III) or (IV) may be converted into the product of Formula (I) by treatment with LiBH 4 which may be formed in situ.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1777269A CH565798A5 (en) | 1969-11-29 | 1969-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1287839A true GB1287839A (en) | 1972-09-06 |
Family
ID=4427992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5640770A Expired GB1287839A (en) | 1969-11-29 | 1970-11-27 |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS4932551B1 (en) |
BE (1) | BE759512A (en) |
CA (1) | CA983938A (en) |
CH (1) | CH565798A5 (en) |
DE (1) | DE2058248C3 (en) |
DK (1) | DK143109C (en) |
FR (1) | FR2077539B1 (en) |
GB (1) | GB1287839A (en) |
NL (1) | NL159385B (en) |
SE (1) | SE391718B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0081047B1 (en) * | 1981-12-07 | 1985-12-18 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Process for the preparation of an optically active lactone, and starting products for the process |
DE3150723A1 (en) * | 1981-12-22 | 1983-06-30 | Basf Ag, 6700 Ludwigshafen | IMPROVED METHOD FOR PRODUCING 1,3-DISUBSTITUTED 4,5-CIS-DICARBOXY-2-IMIDAZOLIDONES |
CH670644A5 (en) * | 1986-12-18 | 1989-06-30 | Lonza Ag | |
CH671227A5 (en) * | 1986-12-02 | 1989-08-15 | Lonza Ag | |
US5162540A (en) * | 1986-12-18 | 1992-11-10 | Lonza Ltd. | Process for the production of (+) biotin |
FI95034C (en) * | 1989-03-15 | 1995-12-11 | Lonza Ag | Process for the preparation of 1,3-substituted tetrahydro-1H-thieno / 3,4-d / imidazole-2 (3H) -one-4-ylidene pentanoic acid ester |
FI935609A (en) * | 1992-12-18 | 1994-06-19 | Lonza Ag | Asymmetric hydrogenation of dihydrofuroimidazole derivatives |
CA2134441A1 (en) * | 1993-04-20 | 1994-10-27 | Martin Eyer | Asymmetric hydrogenation of furoimidazole derivatives |
CA2122511A1 (en) * | 1993-05-14 | 1994-11-15 | John Mcgarrity | Asymmetric hydrogenation of furoimidazole derivatives |
DE10033284A1 (en) * | 2000-07-07 | 2002-01-17 | Merck Patent Gmbh | Process for the production of (+) - biotin |
TW200300676A (en) | 2001-12-04 | 2003-06-16 | Tanabe Seiyaku Co | Biotin intermediate and its production |
CN113121549B (en) * | 2019-12-31 | 2022-08-26 | 江西天新药业股份有限公司 | Method for stereoselectively synthesizing chiral lactone, chiral compound and application thereof |
-
0
- BE BE759512D patent/BE759512A/en not_active IP Right Cessation
-
1969
- 1969-11-29 CH CH1777269A patent/CH565798A5/xx not_active IP Right Cessation
-
1970
- 1970-10-20 NL NL7015355A patent/NL159385B/en not_active IP Right Cessation
- 1970-11-18 CA CA098,431A patent/CA983938A/en not_active Expired
- 1970-11-26 DE DE19702058248 patent/DE2058248C3/en not_active Expired
- 1970-11-26 FR FR7042500A patent/FR2077539B1/fr not_active Expired
- 1970-11-27 GB GB5640770A patent/GB1287839A/en not_active Expired
- 1970-11-27 SE SE1613270A patent/SE391718B/en unknown
- 1970-11-27 DK DK607170A patent/DK143109C/en not_active IP Right Cessation
- 1970-11-28 JP JP10450970A patent/JPS4932551B1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CH565798A5 (en) | 1975-08-29 |
CA983938A (en) | 1976-02-17 |
NL7015355A (en) | 1971-06-02 |
DE2058248C3 (en) | 1980-12-18 |
JPS4932551B1 (en) | 1974-08-31 |
FR2077539A1 (en) | 1971-10-29 |
DK143109C (en) | 1981-09-21 |
DK143109B (en) | 1981-03-30 |
FR2077539B1 (en) | 1973-02-02 |
BE759512A (en) | 1971-05-27 |
NL159385B (en) | 1979-02-15 |
DE2058248B2 (en) | 1980-04-10 |
DE2058248A1 (en) | 1971-06-09 |
SE391718B (en) | 1977-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1287839A (en) | ||
GB1151059A (en) | Method of Producing Hexabromocyclododecane. | |
GB1337370A (en) | Preparing 2-alkoxy-5-methoxybenzaldehydes | |
GB1209725A (en) | Process for the production of acetoacetic acids | |
CA943907A (en) | Plant production of aluminium by electrolysis | |
DK134698B (en) | Process for the production of phosphoric acid. | |
JPS5225733A (en) | Process for preparation of benzaldehydes | |
GB1247714A (en) | Phenylglycine derivatives | |
GB1436779A (en) | Process for separating resorcinol from hydroquinone | |
GB1278368A (en) | Hydroxy-2-piperidinyl carbinols | |
GB1448311A (en) | Process for preparing hexahydrothieno-3,4-d-imidazole-2,4- diones | |
GB1354011A (en) | Production of acetylene glycols | |
CA940072A (en) | Method of producing l-glutamic acid by fermentation | |
GB1241136A (en) | New dioxazines and process for their manufacture | |
JPS5239642A (en) | A process for preparing protocatechualdehyde | |
ES405854A1 (en) | 2-Chloroethanephosphonic acid derivatives | |
AT306255B (en) | Process for the production of new derivatives of acrylic acid substituted by a steroid residue | |
GB1325633A (en) | Cyclopentanediones | |
DK131090B (en) | Process for the production of pure orgotein. | |
GB1414115A (en) | Method for producing 2,6-ditert-butyl-4-cumyl phenol | |
GB1263677A (en) | Process for the preparation of quinoxaline-di-n-oxide-aldehyde | |
DK115982B (en) | Process for the production of β-carotene by aerobic fermentation of the (+) and (-) forms of Blakeslea trispora. | |
GB1273224A (en) | Process for the continuous production of pseudoionones and isomers and derivatives thereof | |
GB1226730A (en) | ||
AU460005B2 (en) | Process forthe production of citric acid by submerged fermentation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
PE20 | Patent expired after termination of 20 years |